‘Hold’ Jubilant Pharmova Shares Maintains Systematix Post Inline Q2 Results – Check Target PriceBy Adminjp / November 3, 2025 Source: ndtvprofit.com Jubilant Pharmova's sterile CMO and allergy Immunotherapy posts strong growth in Q2. Tap fro More